COVID-19 testing service now available from MDNA's UK laboratory: Click here ›

New blood test to accurately detect the presence of clinically significant prostate cancer now available

Today, MDNA Life Sciences announces that its breakthrough Mitomic® Prostate Test (MPTTM) – the world’s most accurate blood test to determine whether a man does or does not have prostate cancer that requires treatment (clinically significant prostate cancer) – is now available for clinical use with the launch of the test in the UK by MDNA’s partner, Aspire Pharma Ltd.